1. Home
  2. HRMY vs CABO Comparison

HRMY vs CABO Comparison

Compare HRMY & CABO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$40.55

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Cable One Inc.

CABO

Cable One Inc.

HOLD

Current Price

$132.34

Market Cap

603.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
CABO
Founded
2017
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Cable & Other Pay Television Services
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
603.1M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
HRMY
CABO
Price
$40.55
$132.34
Analyst Decision
Strong Buy
Hold
Analyst Count
9
3
Target Price
$51.33
$126.00
AVG Volume (30 Days)
789.9K
147.0K
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
2.23%
EPS Growth
50.44
N/A
EPS
3.17
N/A
Revenue
$825,944,000.00
$1,524,897,000.00
Revenue This Year
$23.11
N/A
Revenue Next Year
$16.15
N/A
P/E Ratio
$12.79
N/A
Revenue Growth
21.13
N/A
52 Week Low
$25.52
$96.67
52 Week High
$40.93
$390.25

Technical Indicators

Market Signals
Indicator
HRMY
CABO
Relative Strength Index (RSI) 80.09 57.32
Support Level $38.12 $119.44
Resistance Level $40.00 $128.95
Average True Range (ATR) 1.20 6.61
MACD 0.25 3.79
Stochastic Oscillator 100.00 87.37

Price Performance

Historical Comparison
HRMY
CABO

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About CABO Cable One Inc.

Cable One Inc. is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. From a product standpoint, the majority of revenue comes from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols. Cable One Inc. owns its telecommunications infrastructure.

Share on Social Networks: